Morshaeuser, Laura <br/><br/>
p53-expression in patients with renal cell carcinoma correlates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome models.  [electronic resource] 

 -  Urologic oncology  03 2018 
 - 94.e15-94.e21 p.  digital 
<br/><br/> Publication Type: Journal Article; Validation Study 
<br/><br/><label>ISSN: </label>1873-2496 
<br/><br/><label>Standard No.: </label>10.1016/j.urolonc.2017.11.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Biomarkers, Tumor--analysis<br/>Carcinoma, Renal Cell--mortality<br/>Clinical Decision-Making--methods<br/>Disease Progression<br/>Disease-Free Survival<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Kaplan-Meier Estimate<br/>Kidney--pathology<br/>Kidney Neoplasms--mortality<br/>Male<br/>Middle Aged<br/>Models, Biological<br/>Neoplasm Staging<br/>Nephrectomy<br/>Nomograms<br/>Predictive Value of Tests<br/>Prognosis<br/>Tumor Suppressor Protein p53--metabolism